Effect of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy on Nutritional Status in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Prospective Observational Study
Jingjing Miao,Chaosu Hu,Lin Shen,Xiaozhong Chen,Yuan,Zhong Ye,Feng Jin,Lin Qi,Xuefeng Hu,Ning Zhang,Rensheng Wang,Lin Wang,Cong Wang,Miao Zhu,Haijian Wu,Muping Di,Yuqing Huang,Conghua Xie,Chong Zhao
DOI: https://doi.org/10.1200/jco.2018.36.15_suppl.e18002
IF: 45.3
2018-01-01
Journal of Clinical Oncology
Abstract:e18002 Background: To investigate the influence of neoadjuvant chemotherapy (NACT) plus concurrent chemoradiotherapy (CCRT) on nutritional status in locoregionally advanced nasopharyngeal carcinoma (LANPC) patients. Methods: Patients were recruited from ten hospitals. All patients received NACT plus CCRT. Nutrition related parameters including weight loss (WL), body mass index (BMI), Nutrition Risk Screening 2002 (NRS2002), Patient-Generated Subjective Global Assessment (PG-SGA), and Quality of life (QoL) score (EORTC QLQ-C30) as well as toxicity were recorded before, during, and after treatment. Statistical analyses are using SPSS 22.0. The study was registered on ClinicalTrials.gov, No. NCT02575547. Results: From Jun 2015 to Nov 2016, 186 patients enrolled, of whom 171 were eligible for analysis. The overall incidence of mild and severe malnutrition was 68.5% and 37.4%, as shown in Table 1. Patients with ≥ 2 grade mucositis have higher risks of WL ≥ 10% (P = 0.037), NRS2002 ≥ 3 points (P = 0.002) and PG-SGA ≥ 9 points (P < 0.001). 97.7%, 87.7% and 99.4% patients finished NACT, CCRT and radiotherapy, respectively. Patients with PG-SGA ≥ 9 points and C30-QoL < 50 points had poor chemotherapy compliance (P = 0.014, P < 0.001), and BMI < 18.5 had poor radiotherapy compliance (P = 0.036). Conclusions: Malnutrition was prevalent in LANPC patients treated with NACT plus CCRT, especially during CCRT, even lasted until 1 year after treatment. Its impact on clinical outcomes need long-term follow-up. Table 1 Incidence of nutrition related parameters on each observation points Clinical trial information: NCT02575547. prior NACT after 1 cycle NACT prior RT 4th week of RT end of RT 3 months after RT 1 year after RT WL ≥ 5% (mild malnutrition) 5.3% 6.0% 5.4% 38.7% 68.5% 64.1% 54.1% WL ≥ 10% (severe malnutrition) 0 1.8% 1.8% 7.7% 33.3% 37.4% 28.4% BMI < 18.5 5.8% 7.1% 6.5% 12.5% 19.4% 16.8% 13.5% NRS2002 ≥ 3 points (high risk of malnutrition) 8.2% - 6.9% 54.4% 79.4% 10.9% 6.7% PG-SGA ≥ 4 points (need nutrition treatment) 16.8% - 23.6% 96.7% 96.6% 38.3% 12.2% PG-SGA ≥ 9 points (need nutrition treatment urgently) 3.0% - 3.9% 72.0% 76.6% 6.3% 0 C30-QoL score 73.65 - 71.82 50.76 48.49 71.03 76.64